SANUWAVE Health, Inc. (SNWV)
| Market Cap | 15.66M -94.5% |
| Revenue (ttm) | 41.15M -0.0% |
| Net Income | 3.52M |
| EPS | 0.17 |
| Shares Out | 8.60M |
| PE Ratio | 10.79 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 83,684 |
| Open | 1.560 |
| Previous Close | 1.580 |
| Day's Range | 1.550 - 1.905 |
| 52-Week Range | 1.550 - 35.290 |
| Beta | 1.48 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 10, 2026 |
About SNWV
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and ch... [Read more]
Financial Performance
Financial StatementsNews
SANUWAVE Health Earnings Call Transcript: Q3 2026
Q3 revenue fell 24% YoY as capital sales weakened, while applicator revenue and volume grew. CMS lowered 2027 physician reimbursement for 97610 but raised HOPD rates and enabled same-day billing with other codes.
SANUWAVE Health Quarterly report: Q3 2026
SANUWAVE Health has published its Q3 2026 quarterly earnings report on November 11, 2026.
SANUWAVE Health Earnings release: Q3 2026
SANUWAVE Health released its Q3 2026 earnings on November 11, 2026, summarizing the period's financial results.
SANUWAVE Health Slides: Q3 2026
SANUWAVE Health has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 11, 2026.
Sanuwave Announces Q3 FY2026 Financial Results
Q3 2026 revenues were $8.6 million , down 24% from $11.3 million in Q3 2025. Q3 2026 gross margin was 77.3% , versus 77.6% in Q3 2025.
Sanuwave Will Host a Conference Call on November 11, 2026 at 8:30 AM (ET) to Present Q3 2026 Financial Results
EDEN PRAIRIE, Minn., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will ...
SANUWAVE Health Inc trading resumes
09:36 EST SANUWAVE Health (SNWV) Inc trading resumes
SANUWAVE Health Inc trading halted, volatility trading pause
09:31 EST SANUWAVE Health (SNWV) Inc trading halted, volatility trading pause
Sanuwave Health Comments on 2027 Medicare Physician Fee Schedule Rate for Ultramist
CMS establishes $314.54 reimbursement rate for CPT code 97610 for 2027, an approximately 21% reduction vs 2026 rate of $397.81 2027 Hospital outpatient rate for 97610 code set at $235.04, an approxima...
SANUWAVE Health Earnings Call Transcript: Q2 2026
Q2 2026 saw record applicator sales but a sharp decline in system sales due to used device market saturation and industry disruption from CMS reimbursement cuts. Revenue fell 3% year-over-year, with gross margin and profitability pressured. Guidance was withdrawn pending CMS decisions.
SANUWAVE Health Quarterly report: Q2 2026
SANUWAVE Health has published its Q2 2026 quarterly earnings report on August 7, 2026.
SANUWAVE Health Earnings release: Q2 2026
SANUWAVE Health released its Q2 2026 earnings on August 7, 2026, summarizing the period's financial results.
SANUWAVE Health Slides: Q2 2026
SANUWAVE Health has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 7, 2026.
Sanuwave Announces Q2 FY2026 Financial Results
Q2 2026 revenues were $9.7 million, down 3% from $10.1 million in Q2 2025. Q2 2026 gross margin was 76.2%, versus 78.1% in Q2 2025.
Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results
EDEN PRAIRIE, Minn., July 30, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will ...
Sanuwave Health sees Q2 revenue $9.6M-$9.8M
Sanuwave Health (SNWV) announced that revenues for the second quarter of 2026 are expected to be in the range of $9.6M-$9.8M, above the high end of the revised guidance range…
Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance
EDEN PRAIRIE, Minn., July 13, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the “Company” or “Sanuwave”) (NASDAQ: SNWV), a leading provider of FDA-cleared directed energy systems used in advanced wo...
SANUWAVE Health Transcript: Planet MicroCap Las Vegas 2026
Wound care is undergoing a payer-driven shift to evidence-based medicine, creating opportunities for high-efficacy, cost-effective solutions. UltraMIST’s strong clinical evidence, expanding reimbursement, and consumables-driven model position it for growth, especially as it targets large enterprise accounts.
Sanuwave Health Updates Second Quarter 2026 Guidance
Sanuwave updates guidance for Q2 2026 to $8.5 - $9.5 million Company on pace for record unit sales of applicators in Q2 Market disruption impacting Ultramist system sales EDEN PRAIRIE, Minn., June 16,...
SANUWAVE Health Slides: Investor presentation
SANUWAVE Health has posted slides in relation to its latest quarterly earnings report, which was published on June 16, 2026.
SANUWAVE Health Transcript: AGM 2026
The meeting covered director elections, auditor ratification, and executive compensation votes. Quorum was met, voting was conducted online, and results will be disclosed in a Form 8-K. Only meeting-related questions were addressed during the Q&A.
SANUWAVE Health Earnings Call Transcript: Q1 2026
Record Q1 revenue and strong consumables growth were achieved despite a market freeze from CMS pricing changes. Guidance for 2026 remains robust, with expectations for a stronger second half driven by seasonality and large account engagement.
SANUWAVE Health Quarterly report: Q1 2026
SANUWAVE Health has published its Q1 2026 quarterly earnings report on May 13, 2026.
SANUWAVE Health Earnings release: Q1 2026
SANUWAVE Health released its Q1 2026 earnings on May 13, 2026, summarizing the period's financial results.
SANUWAVE Health Slides: Q1 2026
SANUWAVE Health has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 13, 2026.